247 related articles for article (PubMed ID: 30717910)
1. Coding Molecular Determinants of Thyroid Cancer Development and Progression.
Valvo V; Nucera C
Endocrinol Metab Clin North Am; 2019 Mar; 48(1):37-59. PubMed ID: 30717910
[TBL] [Abstract][Full Text] [Related]
2. Molecular Alterations in Thyroid Carcinoma.
Haroon Al Rasheed MR; Xu B
Surg Pathol Clin; 2019 Dec; 12(4):921-930. PubMed ID: 31672298
[TBL] [Abstract][Full Text] [Related]
3. Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy.
Liu J; Liu Y; Lin Y; Liang J
Endocrinol Metab (Seoul); 2019 Sep; 34(3):215-225. PubMed ID: 31565873
[TBL] [Abstract][Full Text] [Related]
4. Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies.
Aashiq M; Silverman DA; Na'ara S; Takahashi H; Amit M
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31533238
[TBL] [Abstract][Full Text] [Related]
5. Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer.
Yoo SK; Song YS; Lee EK; Hwang J; Kim HH; Jung G; Kim YA; Kim SJ; Cho SW; Won JK; Chung EJ; Shin JY; Lee KE; Kim JI; Park YJ; Seo JS
Nat Commun; 2019 Jun; 10(1):2764. PubMed ID: 31235699
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Targets and Their Inhibitors in Thyroid Cancer Treatment.
Zhang K; Wang J; He Z; Qiu X; Sa R; Chen L
Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111316
[TBL] [Abstract][Full Text] [Related]
7. Association of DNA Promoter Methylation and
Jasmine F; Aschebrook-Kilfoy B; Rahman MM; Zaagman G; Grogan RH; Kamal M; Ahsan H; Kibriya MG
Curr Oncol; 2023 Mar; 30(3):2978-2996. PubMed ID: 36975440
[TBL] [Abstract][Full Text] [Related]
8. CpG island status as an epigenetic alteration for NIS promoter in thyroid neoplasms; a cross-sectional study with a systematic review.
Zarkesh M; Arab N; Abooshahab R; Heydarzadeh S; Sheikholeslami S; Nozhat Z; Salehi Jahromi M; Fanaei SA; Hedayati M
Cancer Cell Int; 2022 Oct; 22(1):310. PubMed ID: 36221112
[TBL] [Abstract][Full Text] [Related]
9. Redox Homeostasis in Thyroid Cancer: Implications in Na
Cazarin J; Dupuy C; Pires de Carvalho D
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682803
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of the Prognosis and Drug Sensitivity of Differentiation-Related lncRNAs in Papillary Thyroid Cancer.
Wang W; Bai N; Li X
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267662
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS.
Oh JM; Ahn BC
Theranostics; 2021; 11(13):6251-6277. PubMed ID: 33995657
[TBL] [Abstract][Full Text] [Related]
12. To Explore the Inhibitory Mechanism of Quercetin in Thyroid Papillary Carcinoma through Network Pharmacology and Experiments.
Sun Y; Xie W; Kang N; Yi J; Ruan X; Hu L; Zhao J; Zheng X; Wei S; Gao M
Dis Markers; 2022; 2022():9541080. PubMed ID: 36510497
[TBL] [Abstract][Full Text] [Related]
13. The promising role and prognostic value of miR-198 in human diseases.
Wang X; Zhu Y; Xie Q
Am J Transl Res; 2022; 14(4):2749-2766. PubMed ID: 35559396
[TBL] [Abstract][Full Text] [Related]
14. Cervical carcinoma high-expressed long non-coding RNA 1 promotes papillary thyroid carcinoma cell proliferation and invasion.
Shi P; Liu Y; Zhang M; Yang J; Jing S; Yang D; Liu F; Wu Y; Shi H; Geng C
Transl Cancer Res; 2021 Sep; 10(9):4158-4168. PubMed ID: 35116712
[TBL] [Abstract][Full Text] [Related]
15. HYOU1 facilitates proliferation, invasion and glycolysis of papillary thyroid cancer via stabilizing LDHB mRNA.
Wang JM; Jiang JY; Zhang DL; Du X; Wu T; Du ZX
J Cell Mol Med; 2021 May; 25(10):4814-4825. PubMed ID: 33792181
[TBL] [Abstract][Full Text] [Related]
16. Identifying M1 Macrophage-Related Genes Through a Co-expression Network to Construct a Four-Gene Risk-Scoring Model for Predicting Thyroid Cancer Prognosis.
Zhuang G; Zeng Y; Tang Q; He Q; Luo G
Front Genet; 2020; 11():591079. PubMed ID: 33193731
[TBL] [Abstract][Full Text] [Related]
17. Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist?
Szpak-Ulczok S; Pfeifer A; Rusinek D; Oczko-Wojciechowska M; Kowalska M; Tyszkiewicz T; Cieslicka M; Handkiewicz-Junak D; Fujarewicz K; Lange D; Chmielik E; Zembala-Nozynska E; Student S; Kotecka-Blicharz A; Kluczewska-Galka A; Jarzab B; Czarniecka A; Jarzab M; Krajewska J
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610693
[TBL] [Abstract][Full Text] [Related]
18. De-differentiation of papillary thyroid carcinoma into squamous cell carcinoma in an elderly patient: A case report.
Thewjitcharoen Y; Krittiyawong S; Butadej S; Nakasatien S; Polchart S; Junyangdikul P; Kanchanapituk A; Himathongkam T
Medicine (Baltimore); 2020 Apr; 99(16):e19892. PubMed ID: 32312017
[TBL] [Abstract][Full Text] [Related]
19. Ethanol Ablation of Neck Metastases from Differentiated Thyroid Carcinoma.
Paz-Fumagalli R; Li X; Smallridge RC
Semin Intervent Radiol; 2019 Dec; 36(5):381-385. PubMed ID: 31798211
[TBL] [Abstract][Full Text] [Related]
20. Clonal Reconstruction of Thyroid Cancer: An Essential Strategy for Preventing Resistance to Ultra-Precision Therapy.
McGonagle ER; Nucera C
Front Endocrinol (Lausanne); 2019; 10():468. PubMed ID: 31379741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
